AstraZeneca reported 3.09B in Pre-Tax Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Alcon AG ALC:SW 402M 95M
Amgen AMGN:US $ 2727M 56M
Astrazeneca AZN:US $ 3709M 624M
Biogen BIIB:US $ 903.4M 316.6M
Bristol Myers Squibb BMY:US $ 5386M 595M
Fresenius FRE:GR € 784M 217M
Fresenius Medical Care FME:GR € 321.57M 94.43M
Genmab GEN:DC DK 612M 354M
GRIFOLS GRF:SM € 221M 44.67M
Merck MRK:GR € 1306.2M 218.7M
Merk MRK:US $ 6309M 1525M
Novartis NOVN:VX SF 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Sanofi SAN:FP € 2965M 804M